Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View

Healthcare, Год журнала: 2023, Номер 11(6), С. 906 - 906

Опубликована: Март 21, 2023

The long-term problems of head and neck cancer survivors (HNCS) are not well known. In a cross-sectional international study aimed at exploring the quality life in this population, 1114 HNCS were asked to state their two most serious effects. A clinician recorded responses during face-to-face appointments. list 15 example was provided, but free text field also available. total 1033 responded question. frequent 'dry mouth' (DM) (n = 476; 46%), 'difficulty swallowing/eating' (DSE) 408; 40%), 'hoarseness/difficulty speaking' (HDS) 169; 16%), 'pain neck' (PHN) 142; 14%). 5% reported no problems. Logistic regression adjusted for age, gender, treatment, tumor stage site showed increased odds reporting DM DSE chemo-radiotherapy (CRT) alone compared surgery (odds ratio (OR): 4.7, 95% confidence interval (CI): 2.5-9.0; OR: 2.1, CI: 1.1-3.9), decreased HDS PHN (OR: 0.3, 0.1-0.6; 0.2, 0.1-0.5). Survivors with UICC IV diagnosis I had 1.9, 1.2-3.0). Laryngeal reduced oropharynx 0.4, 0.3-0.6) 7.2, 4.3-12.3). This provides evidence among HNCS.

Язык: Английский

---

Self-perception of oropharyngeal cancer patients regarding the impacts of chemoradiotherapy treatments on swallowing and voice functions

Revista de Logopedia Foniatría y Audiología, Год журнала: 2025, Номер 45(2), С. 100518 - 100518

Опубликована: Фев. 19, 2025

Язык: Английский

---

Swallowing exercises for head and neck cancer patients: A systematic review and meta-analysis of randomized control trials

International Journal of Nursing Studies, Год журнала: 2020, Номер 114, С. 103827 - 103827

Опубликована: Ноя. 11, 2020

Язык: Английский

---

Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer

Radiotherapy and Oncology, Год журнала: 2023, Номер 190, С. 109958 - 109958

Опубликована: Окт. 21, 2023

Proton radiotherapy offers a dosimetric advantage compared to photon therapy in sparing normal tissue, but the clinical evidence for toxicity reductions treatment of head and neck cancer is limited. The Danish Head Neck Cancer Group (DAHANCA) has initiated DAHANCA 35 randomised trial clarify value proton (NCT04607694). performed an enriched population patients selected by anticipated benefit reduce risk late dysphagia or xerostomia based on tissue complication probability (NTCP) modelling. We present our considerations design test selection procedure conducted before initiating study.

Язык: Английский

---

Precision Meets Repurposing: Innovative Approaches in Human Papillomavirus and Epstein-Barr Virus-Driven Cancer Therapy

Cancer Letters, Год журнала: 2024, Номер 607, С. 217318 - 217318

Опубликована: Ноя. 8, 2024

Язык: Английский

---